Core Insights - Syra Health Corp. reported a decline in revenue for Q3 2025, primarily due to federal spending cuts impacting state and county government budgets, with revenue falling to $1.7 million from $2.3 million in Q3 2024 [5][7] - The Population Health business unit experienced significant growth of 96% year-over-year, indicating strong market demand for its solutions [3][8] - The company improved its gross margin by 300 basis points to 33% and reduced its net loss by 46% through cost management and operational efficiency [3][7] Financial Performance - Q3 2025 revenue was $1.7 million, down from $2.3 million in Q3 2024, largely due to federal budget cuts [5][14] - Population Health segment revenue reached $1,280,011, up from $652,298 in Q3 2024, driven by upselling to state health departments and private sector customers [8][14] - Gross margin improved to 33% in Q3 2025 from 30% in Q3 2024, attributed to a strategic focus on higher-margin business units [8][14] - Net loss decreased to ($225,902) in Q3 2025 from ($417,535) in Q3 2024, reflecting improved operational efficiency [7][14] Cost Management - Total operating expenses for Q3 2025 were $786,712, a 28% decline from $1,097,208 in the previous year, due to disciplined cost management [9][14] - Salaries and benefits decreased by 43% to $336,390, resulting from workforce optimization efforts [9][14] - Selling, general, and administrative expenses fell by 12% to $252,384 as part of overhead reduction initiatives [11][14] Strategic Focus - The company is refining its strategy to concentrate on its successful Population Health solutions, which is contributing to growth in its sales pipeline [4][5] - Syra Health's focus on targeted upselling and expansion into the private sector is expected to enhance its market position as federal budget clarity improves [4][5] Cash Position - As of September 30, 2025, Syra Health had cash and cash equivalents of $2.0 million and no long-term debt [11][12] - The company continues to manage its cash flow effectively, with a net cash used in operating activities of ($158,554) for the quarter [15]

Core Insights - Syra Health Corp. will report its financial results for the three months ended September 30, 2025, on November 12, 2025, before market opening [1]. Company Overview - Syra Health is a healthcare solutions company that serves both public and private healthcare organizations, focusing on innovative solutions that positively impact entire populations [2]. - The company specializes in healthcare prevention, expanding access, and delivering affordable solutions, with capabilities in healthcare analytics that provide proactive, actionable insights [2]. - Syra Health's digital health solutions are HIPAA-compliant and fully accessible, enabling measurable health outcomes in regulated healthcare environments [2]. - The company also emphasizes training and education to help healthcare organizations reduce costs and deliver consistent, high-quality care [2].